Shares

41 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$17.13 - $26.91 $6,355 - $9,983
-371 Reduced 5.66%
6,181 $127,000
Q3 2023

Nov 14, 2023

BUY
$25.8 - $39.97 $12,358 - $19,145
479 Added 7.89%
6,552 $194,000
Q2 2023

Aug 10, 2023

BUY
$20.94 - $38.01 $127,168 - $230,834
6,073 New
6,073 $217,000
Q1 2022

May 12, 2022

SELL
$48.25 - $100.49 $288,245 - $600,327
-5,974 Closed
0 $0
Q4 2021

Jun 21, 2023

BUY
$88.71 - $120.43 $529,953 - $719,448
5,974 New
5,974 $597,000
Q4 2021

Mar 30, 2023

SELL
$88.71 - $120.43 $4,169 - $5,660
-47 Reduced 0.78%
5,974 $597,000
Q4 2021

Feb 15, 2022

SELL
$88.71 - $120.43 $4,169 - $5,660
-47 Reduced 0.78%
5,974 $598,000
Q3 2021

Jun 21, 2023

BUY
$98.77 - $132.17 $594,694 - $795,795
6,021 New
6,021 $752,000
Q3 2021

Mar 30, 2023

SELL
$98.77 - $132.17 $19,556 - $26,169
-198 Reduced 3.18%
6,021 $752,000
Q3 2021

Nov 15, 2021

SELL
$98.77 - $132.17 $19,556 - $26,169
-198 Reduced 3.18%
6,021 $753,000
Q2 2021

Jun 21, 2023

BUY
$109.77 - $165.68 $682,659 - $1.03 Million
6,219 New
6,219 $772,000
Q2 2021

Mar 30, 2023

BUY
$109.77 - $165.68 $27,442 - $41,420
250 Added 4.19%
6,219 $772,000
Q2 2021

Aug 16, 2021

BUY
$109.77 - $165.68 $682,001 - $1.03 Million
6,213 Added 103550.0%
6,219 $772,000
Q1 2021

Jun 26, 2023

BUY
$127.04 - $179.1 $758,301 - $1.07 Million
5,969 New
5,969 $911 Million
Q1 2021

Mar 30, 2023

SELL
$127.04 - $179.1 $34,046 - $47,998
-268 Reduced 4.3%
5,969 $911,000
Q1 2021

May 14, 2021

SELL
$127.04 - $179.1 $791,586 - $1.12 Million
-6,231 Reduced 99.9%
6 $911,000
Q4 2020

Jun 22, 2023

BUY
$99.96 - $135.93 $623,450 - $847,795
6,237 New
6,237 $803,000
Q4 2020

Mar 30, 2023

BUY
$99.96 - $135.93 $42,183 - $57,362
422 Added 7.26%
6,237 $803,000
Q4 2020

Feb 16, 2021

BUY
$99.96 - $135.93 $42,183 - $57,362
422 Added 7.26%
6,237 $804,000
Q3 2020

Jun 26, 2023

BUY
$80.32 - $111.8 $467,060 - $650,117
5,815 New
5,815 $650,000
Q3 2020

Mar 30, 2023

SELL
$80.32 - $111.8 $6,827 - $9,503
-85 Reduced 1.44%
5,815 $650,000
Q3 2020

Nov 13, 2020

SELL
$80.32 - $111.8 $6,827 - $9,503
-85 Reduced 1.44%
5,815 $650,000
Q2 2020

Jun 26, 2023

BUY
$60.49 - $97.5 $356,891 - $575,250
5,900 New
5,900 $478,000
Q2 2020

Mar 30, 2023

BUY
$60.49 - $97.5 $200,282 - $322,822
3,311 Added 127.89%
5,900 $478,000
Q2 2020

Aug 14, 2020

BUY
$60.49 - $97.5 $200,282 - $322,822
3,311 Added 127.89%
5,900 $479,000
Q1 2020

Jul 12, 2023

BUY
$59.04 - $88.81 $152,854 - $229,929
2,589 New
2,589 $180,000
Q1 2020

Mar 30, 2023

SELL
$59.04 - $88.81 $4,841 - $7,282
-82 Reduced 3.07%
2,589 $180,000
Q1 2020

May 15, 2020

SELL
$59.04 - $88.81 $4,841 - $7,282
-82 Reduced 3.07%
2,589 $180,000
Q4 2019

Jul 12, 2023

BUY
$59.49 - $82.78 $158,897 - $221,105
2,671 New
2,671 $208,000
Q4 2019

Mar 30, 2023

SELL
$59.49 - $82.78 $1,308 - $1,821
-22 Reduced 0.82%
2,671 $208,000
Q4 2019

Feb 14, 2020

SELL
$59.49 - $82.78 $1,308 - $1,821
-22 Reduced 0.82%
2,671 $209,000
Q3 2019

Jul 12, 2023

BUY
$62.59 - $110.3 $168,554 - $297,037
2,693 New
2,693 $171,000
Q3 2019

Mar 30, 2023

SELL
$62.59 - $110.3 $128,559 - $226,556
-2,054 Reduced 43.27%
2,693 $171,000
Q3 2019

Nov 14, 2019

SELL
$62.59 - $110.3 $128,559 - $226,556
-2,054 Reduced 43.27%
2,693 $172,000
Q2 2019

Jul 12, 2023

BUY
$63.94 - $91.11 $303,523 - $432,499
4,747 New
4,747 $409,000
Q1 2019

Jul 13, 2023

BUY
$34.3 - $97.98 $162,822 - $465,111
4,747 New
4,747 $364,000
Q1 2019

Mar 30, 2023

BUY
$34.3 - $97.98 $162,822 - $465,111
4,747 New
4,747 $364,000
Q1 2019

May 16, 2019

SELL
$34.3 - $97.98 $614,484 - $1.76 Million
-17,915 Reduced 79.05%
4,747 $364,000
Q1 2019

May 15, 2019

BUY
$34.3 - $97.98 $560,667 - $1.6 Million
16,346 Added 258.8%
22,662 $585,000
Q4 2018

Jul 13, 2023

BUY
$29.2 - $46.1 $184,427 - $291,167
6,316 New
6,316 $237,000
Q4 2018

Feb 14, 2019

BUY
$29.2 - $46.1 $184,427 - $291,167
6,316 New
6,316 $237,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.75B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.